88 related articles for article (PubMed ID: 7755279)
1. Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes.
Van Heugten HA; De Jonge HW; Bezstarosti K; Sharma HS; Verdouw PD; Lamers JM
Ann N Y Acad Sci; 1995 Mar; 752():343-52. PubMed ID: 7755279
[No Abstract] [Full Text] [Related]
2. Calcium and the endothelin-1 and alpha 1-adrenergic stimulated phosphatidylinositol cycle in cultured rat cardiomyocytes.
van Heugten HA; de Jonge HW; Bezstarosti K; Lamers JM
J Mol Cell Cardiol; 1994 Aug; 26(8):1081-93. PubMed ID: 7528283
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide-generated messengers in cardiac signal transduction.
van Heugten HA; Eskildsen-Helmond YE; de Jonge HW; Bezstarosti K; Lamers JM
Mol Cell Biochem; 1996 Apr 12-26; 157(1-2):5-14. PubMed ID: 8739223
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy.
Lembo G; Hunter JJ; Chien KR
Ann N Y Acad Sci; 1995 Mar; 752():115-27. PubMed ID: 7755250
[No Abstract] [Full Text] [Related]
5. PKCepsilon-PKD1 signaling complex at Z-discs plays a pivotal role in the cardiac hypertrophy induced by G-protein coupling receptor agonists.
Iwata M; Maturana A; Hoshijima M; Tatematsu K; Okajima T; Vandenheede JR; Van Lint J; Tanizawa K; Kuroda S
Biochem Biophys Res Commun; 2005 Feb; 327(4):1105-13. PubMed ID: 15652511
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiological properties of neonatal rat ventricular myocytes with alpha1-adrenergic-induced hypertrophy.
Gaughan JP; Hefner CA; Houser SR
Am J Physiol; 1998 Aug; 275(2):H577-90. PubMed ID: 9683447
[TBL] [Abstract][Full Text] [Related]
7. Distinct alpha 1-adrenergic agonist- and endothelin-1-evoked phosphoinositide cycle responses in cultured neonatal rat cardiomyocytes.
de Jonge HW; van Heugten HA; Bezstarosti K; Lamers JM
Biochem Biophys Res Commun; 1994 Aug; 203(1):422-9. PubMed ID: 8074687
[TBL] [Abstract][Full Text] [Related]
8. Effects of pregnancy on agonist-stimulated PI hydrolysis in cardiomyocytes.
Orfali KA; Sugden PH; Sugden MC
Biochem Soc Trans; 1993 Nov; 21(4):363S. PubMed ID: 8131941
[No Abstract] [Full Text] [Related]
9. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of alpha1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy.
Grupp IL; Lorenz JN; Walsh RA; Boivin GP; Rindt H
Am J Physiol; 1998 Oct; 275(4):H1338-50. PubMed ID: 9746484
[TBL] [Abstract][Full Text] [Related]
11. Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism.
Ito H; Adachi S; Tamamori M; Fujisaki H; Tanaka M; Lin M; Akimoto H; Marumo F; Hiroe M
J Mol Cell Cardiol; 1996 Jun; 28(6):1271-7. PubMed ID: 8782068
[TBL] [Abstract][Full Text] [Related]
12. The renin-angiotensin system and cardiac hypertrophy.
Yamazaki T; Komuro I; Shiojima I; Yazaki Y
Heart; 1996 Nov; 76(3 Suppl 3):33-5. PubMed ID: 8977363
[No Abstract] [Full Text] [Related]
13. Signaling hypertrophy: how many switches, how many wires.
Homcy CJ
Circulation; 1998 May; 97(19):1890-2. PubMed ID: 9609078
[No Abstract] [Full Text] [Related]
14. Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs.
Autelitano DJ; Woodcock EA
J Mol Cell Cardiol; 1998 Aug; 30(8):1515-23. PubMed ID: 9737938
[TBL] [Abstract][Full Text] [Related]
15. Effect of amlodipine on mesangial cell proliferation and protein synthesis.
Shultz PJ; Raij L
Am J Hypertens; 1992 Dec; 5(12 Pt 1):912-4. PubMed ID: 1285940
[TBL] [Abstract][Full Text] [Related]
16. [Endothelin-1 as an autocrine factor in hypertrophy of cardiomyocytes].
Ito H; Hiroe M; Hirata Y; Adachi S; Tujino M; Marumo F
Jpn Circ J; 1992; 56 Suppl 5():1314-8. PubMed ID: 1291715
[No Abstract] [Full Text] [Related]
17. [Modelling of myocardial hypertrophy in vitro for solving problems of medicinal correction].
Moiseeva OM; Semenova EG; Polevaia EV; Selivanova GV; Vlasova TD; Khirmanov VN; Pinaev GP
Tsitologiia; 1998; 40(12):1025-30. PubMed ID: 10188217
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes.
Luo JD; Xie F; Zhang WW; Ma XD; Guan JX; Chen X
Br J Pharmacol; 2001 Jan; 132(1):159-64. PubMed ID: 11156573
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ventricular myocytes from the newborn pig heart.
Beinlich CJ; Vitkauskas KJ; Morgan HE
J Mol Cell Cardiol; 1998 Jul; 30(7):1263-74. PubMed ID: 9710795
[TBL] [Abstract][Full Text] [Related]
20. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
